X. Zhang, L. Dai et al.
Synthesis of 5a: Typical procedure: nBuLi (5.28 mL, 2.5m in hexane,
13.2 mmol) was added dropwise to a cooled (À788C) solution of diphen-
ylphosphane (2.32 mL, 13.2 mmol) in THF (10 mL). After stirring for
10 min, the reaction mixture was allowed to warm to RT and stirred for
30 min. The reaction mixture was cooled to À788C and (1.05 g,
1.6 g, 4.6 mmol), and BH3 (1.0m in THF, 200 mL, 200 mmol). Yield: 4.9 g
(68.9%); white solid; H NMR (400 MHz, CDCl3): d=7.84 (t, J=6.4 Hz,
1
G
ACHTUNGTRENNUNG
16H), 7.66 (d, J=6.4 Hz, 16H), 6.99 (t, J=7.6 Hz, 2H), 6.63 (d, J=
7.6 Hz, 4H), 3.52 (d, J=13.6 Hz, 8H), 1.40–0.60 ppm (brs, 12H);
13C NMR (100 MHz, CDCl3): d=138.6 (t, J=7.7 Hz), 134.3 (d, J=
52.3 Hz), 133.3 (qd, 1J=33.6, 2J=2.3 Hz), 132.5 (d, J=9.5 Hz), 129.7 (d,
J=1.5 Hz), 128.5, 126.0 (dd, 1J=9.8, 2J=3.8 Hz), 123.3 (q, J=270.1 Hz),
29.6 ppm (d, J=33.7 Hz); 19F NMR (376 MHz, CDCl3): d=À63.4 ppm;
31P NMR (161 MHz, CDCl3): d=16.2 ppm; HRMS (ESI): m/z: calcd for
C72H58B4F24P4: 1546.3478 [M]+; found: 1546.3466.
4
3 mmol) in THF (10 mL) was added dropwise. After addition, the reac-
tion mixture was allowed to warm to RT slowly and stirred overnight.
The reaction mixture was cooled to 08C and a cold solution of BH3
(1.0m in THF, 132 mL, 132 mmol) was added dropwise. The mixture was
allowed to warm to RT and stirring was continued for 4 h. The reaction
mixture was cooled to 08C and water (20 mL) was added carefully to
quench the excess BH3. Volatile material was removed under vacuum
and CH2Cl2 (50 mL) and water (50 mL) were added to the residue. The
mixture was stirred for 10 min until all of the residue dissolved. The or-
ganic phase was separated and the aqueous phase was extracted with
CH2Cl2 (2ꢂ25 mL). The combined organic phase was washed with a satu-
rated aqueous solution of NaCl (50 mL) and dried with Na2SO4. The sol-
vent was removed under reduced pressure to obtain an off-white solid.
EtOAc (10 mL) was added to the crude solid and the resulting suspen-
sion was stirred for 30 min and filtered. The residue was washed with
cold EtOAc (2ꢂ5 mL) to give the pure borane-protected title compound
5a as a colorless solid (2.5 g, 73.8%). 1H NMR (300 MHz, CDCl2): d=
7.58–7.52 (m, 16H), 7.45–7.39 (m, 8H), 7.36–7.31 (m, 16H), 7.03–6.97 (m,
2H), 6.87–6.84 (m, 4H), 3.16 (d, J=13.4 Hz, 8H), 1.53–0.75 ppm (brs,
12H); 13C NMR (75 MHz, CD2Cl2): d=133.1, 132.5 (d, J=9.1 Hz), 131.5,
131.3, 130.6, 130.4, 129.2 (d, J=9.9 Hz), 127.5, 30.2 ppm (d, J=30 Hz);
31P NMR (146 Hz, CD2Cl2): d=15.2 ppm; HRMS (ES+): m/z: calcd for
C64H66NaP4B4: 1025.4385 [M+Na+]; found: 1025.4431.
Compound 1c: Prepared according to the typical procedure by using
complex 5c (773 mg, 0.5 mmol) and DABCO (0.448 g, 4.0 mmol). Yield:
559 mg (75.0%); white solid; 1H NMR (400 MHz, CDCl3): d=7.42 (d,
J=7.6 Hz, 16H), 7.21 (t, J=18.2 Hz, 16H), 6.97 (t, J=7.6 Hz, 2H), 6.70
(d, J=7.6 Hz, 4H), 3.20 ppm (s, 8H); 13C NMR (100 MHz, CDCl3): d=
142.7 (t, J=26.4 Hz), 138.6, 136.2 (d, J=10.8 Hz), 133.2 (d, J=30.0 Hz),
131.4 (q, J=33.5 Hz), 128.7 (d, J=4.5 Hz), 128.2, 125.4 (t, J=3.1 Hz),
123.8 (q, J=270.2 Hz), 34.9 ppm (dd, 1J=10.2, 2J=5.4 Hz); 19F NMR
(376 MHz, CDCl3): d=À62.9 ppm; 31P NMR (146 MHz, CDCl3): d=
À14.1 ppm; HRMS (ESI): m/z: calcd for C72H47F24P4: 1491.2245
AHCTUNGTRENNUNG
[M+H+]; found: 1491.2237.
Complex 5d: Prepared according to the typical procedure by using di-
AHCTUNGERTG(NNUN 4-methylphenyl)phosphane (9.1 g, 42.8 mmol), nBuLi (2.5m in hexane,
17.2 mL, 42.8 mmol), 2,2’,6,6’-tetrakis(chloromethyl)biphenyl (3.4 g,
9.7 mmol), and BH3 (1.0m in THF, 200 mL, 200 mmol) in THF (250 mL).
Yield: 7.6 g (71.2%); white solid; 1H NMR (400 MHz, CDCl3): d=7.48
(t, J=9.2 Hz, 16H), 7.13–7.08 (m, 16H), 6.97 (t, J=7.8 Hz, 2H), 6.85 (d,
J=7.8 Hz, 4H), 3.17 (d, J=13.6 Hz, 8H), 2.35 (s, 24H), 1.15–0.85 ppm
(brs, 12H); 13C NMR (100 MHz, CDCl3): d=141.1 (d, J=2.2 Hz), 138.8
(d, J=7.7 Hz), 132.9, 132.0 (d, J=9.4 Hz), 129.7 (d, J=5.0 Hz), 127.9,
127.4, 127.1, 29.9 (d, J=35 Hz), 21.3 ppm; 31P NMR (161 MHz, CDCl3):
d=13.3 ppm; HRMS (ESI): m/z: calcd for C72H82B4P4: 1114.5722 [M]+;
found: 1114.5739.
Synthesis of ligand 1a: Typical procedure: Compound 5a (501 mg,
0.5 mmol) was added in portions to a solution of DABCO (448 mg,
4 mmol) in toluene (10 mL). The resulting suspension was stirred for
30 min at RT then slowly heated to 608C. Stirring was continued for 6 h
at 608C then the reaction mixture was cooled to RT and additional tolu-
ene (10 mL) was added. The diluted solution was charged on a short
silica gel column by cannula and eluted with toluene (40 mL). The sol-
vent was removed under vacuum to give the desired ligand 1a as a white
solid (376 mg, 79.4%). 1H NMR (300 MHz, CDCl2): d=7.32–7.22 (m,
40H), 6.91–6.86 (m, 2H), 6.76–6.74 (m, 4H), 3.24 ppm (s, 8H); 13C NMR
(75 MHz, CD2Cl2): d=139.6, 139.3, 137.1, 137.0, 133.5, 133.3, 128.9, 128.7,
Compound 1d: Prepared according to the typical procedure by using
complex 5d (1.10 g, 1.0 mmol) and DABCO (0.896 g, 8.0 mmol). Yield:
1
825 mg (78.0%); white solid; H NMR (400 MHz, CDCl3): d=7.16 (t, J=
7.2 Hz, 16H), 7.04 (d, J=7.2 Hz, 16H), 6.90 (t, J=7.6 Hz, 2H), 6.78 (d,
J=7.6 Hz, 4H), 3.16 (s, 8H), 2.33 ppm (s, 24H); 13C NMR (100 MHz,
CDCl3): d=138.1, 136.8 (d, J=11.4 Hz), 135.9 (d, J=14.5 Hz), 133.0 (d,
J=20.1 Hz), 129.4 (d, J=10.1 Hz), 129.0 (d, J=6.8 Hz), 128.0 (d, J=
5.1 Hz), 126.9, 34.7 (d, J=14.1 Hz), 21.3 ppm; 31P NMR (146 MHz,
CDCl3): d=À16.4 ppm; HRMS (ESI): m/z: calcd for C72H71P4: 1059.4501
[M+H+]; found: 1059.4522.
31
127.4, 35.0 ppm (d, J=25.8 Hz); P NMR (146 Hz, CD2Cl2): d=À15.3;
HRMS (ES+): m/z: calcd for C64H55P4: 947.3254 [M+H]+; found:
947.3237.
Complex 5b: Prepared according to the typical procedure by using
di(3,5-difluorophenyl)phosphane (7.9 g, 30.6 mmol), nBuLi (2.5m in
hexane, 12.3 mL, 30.6 mmol), 2,2’,6,6’-tetrakis(chloromethyl)biphenyl
(2.4 g, 6.9 mmol), and BH3 (1.0m in THF, 300 mL, 300 mmol). Yield:
Complex 5e: Prepared according to the typical procedure by using di-
(m-trifluoromethylphenyl)phosphane (8.3 g, 25.7 mmol), nBuLi (2.5m in
hexane, 10.3 mL, 25.7 mmol), 2,2’,6,6’-tetrakis(chloromethyl)biphenyl
(2.0 g, 5.8 mmol), and BH3 (250 mL, 1.0m in THF, 250 mmol). Yield:
6.0 g (67.1%); white solid; 1H NMR (400 MHz, CD2Cl2): d=7.98 (d, J=
10.8 Hz, 8H), 7.88 (t, J=8.8 Hz, 8H), 7.75 (t, J=8.8 Hz, 8H), 7.57 (td,
1J=7.6 Hz, 2J=2.0 Hz, 8H), 6.96 (t, J=8.0 Hz, 2H), 6.62 (d, J=8.0 Hz,
4H), 3.47 (d, J=13.2 Hz, 8H), 1.51–0.60 ppm (brs, 12H); 13C NMR
(100 MHz, CD2Cl2): d=139.3 (t, J=7.8 Hz), 135.9 (d, J=7.8 Hz), 132.5
(d, J=66.2 Hz), 132.2 (qd, 1J=32.7, 2J=10.9 Hz), 130.6, 130.4 (d, J=
9.3 Hz), 130.3 (dd, 1J=6.0, 2J=1.0 Hz), 129.4 (dt, 1J=11.9, 2J=3.6 Hz),
1
5.1 g (64.1%); white solid; H NMR (400 MHz, CDCl3): d=7.25–7.14 (m,
16H), 7.12 (t, J=8.0 Hz, 2H), 6.99–6.92 (m, 16H), 6.74 (d, J=8.0 Hz,
4H), 3.34 (d, J=13.6 Hz, 8H), 1.45–0.52 ppm (brs, 12H); 13C NMR
(100 MHz, CDCl3): d=163.1 (ddd, 1J=254.2, 2J=16.1 Hz, 3J=11.8 Hz),
138.1, 133.5 (dt, 1J=52.3, 2J=8.0 Hz), 132.1, 129.9 (dd, 1J=4.6, 2J=
1.5 Hz), 128.8, 115.1 (ddd, 1J=18.5, 2J=10.5, 3J=8.6 Hz), 107.8 (t, J=
24.9 Hz), 29.8 ppm (d, J=33.6 Hz); 19F NMR (376 MHz, CDCl3): d=
À105.2 ppm; 31P NMR (161 MHz, CDCl3): d=19.0 ppm; HRMS (ESI):
m/z: calcd for C64H50B4F16P4: 1290.298 [M]+; found: 1290.296.
1
2
129.2 (t, J=4.3 Hz), 128.8, 121.4 (qd, J=270.2, J=1.7 Hz), 30.6 ppm (d,
J=33.8 Hz); 19F NMR (376 MHz, CD2Cl2): d=À63.2 ppm; 31P NMR
(161 MHz, CD2Cl2): d=17.0 ppm; HRMS (ESI): m/z: calcd for
C72H58B4F24P4: 1546.3478 [M]+; found: 1546.3463.
Compound 1b: Prepared according to the typical procedure by using
complex 5b (1.3 g, 1.0 mmol) and DABCO (0.896 g, 8.0 mmol). Yield:
1
901 mg (73.0%); white solid; H NMR (400 MHz, CDCl3): d=7.10 (t, J=
7.6 Hz, 2H), 6.85–6.72 (m, 28H), 3.21 ppm (s, 8H); 13C NMR (100 MHz,
CDCl3): d=141.8, 138.3 (d, J=24 Hz), 135.6 (dd, 1J=5.5, 2J=3.2 Hz),
130.9, 129.1, 128.9 (q, J=2.8 Hz), 128.5, 128.2, 125.3, 115.4 (td, 1J=14,
2J=7.3 Hz), 105.0 (t, J=24.8), 35.0 ppm (q, J=5.8 Hz); 19F NMR
(376 MHz, CDCl3): d=À108.1 ppm; 31P NMR (146 MHz, CDCl3): d=
À11.1 ppm; HRMS (ESI): m/z: calcd for C64H39F16P4: 1235.8634
Compound 1e: Prepared according to the typical procedure by using
complex 5e (1.5 g, 1.0 mmol) and DABCO (0.896 g, 8.0 mmol). Yield:
1
954 mg (64.0%); white solid; H NMR (400 MHz, CDCl3): d=7.58 (t, J=
6.4 Hz, 8H), 7.48 (d, J=3.2 Hz, 8H), 7.42–7.33 (m, 16H), 6.98 (t, J=
7.6 Hz, 2H), 6.64 (d, J=7.6 Hz, 4H), 3.28 ppm (s, 8H); 13C NMR
(100 MHz, CDCl3): d=150.6, 139.4 (d, J=8.0 Hz), 138.4, 136.0 (d, J=
74.4 Hz), 134.1, 131.0 (q, J=32.7 Hz), 129.5 (d, J=20.8 Hz), 129.0, 128.6,
128.1, 127.9, 125.8 (d, J=3.7 Hz), 121.4 (q, J=397.7 Hz), 35.4 ppm (dd,
1J=33.8, 2J=5.1 Hz); 19F NMR (376 MHz, CDCl3): d=À62.8 ppm;
ACHTUNGTRENNUNG
[M+H]+; found: 1235.8623.
Complex 5c: Prepared according to the typical procedure by using di-
(p-trifluoromethylphenyl)phosphane (6.5 g, 20.3 mmol), nBuLi (2.5m in
hexane, 8.1 mL, 20.3 mmol), 2,2’,6,6’-tetrakis(chloromethyl)biphenyl (5c;
4942
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 4938 – 4943